James Y Dai

11PUBLICATIONS
107CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)Probability theoryCell and nuclear division
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 04, 2026
Modeled sojourn time and sensitivity for detecting preclinical cancers retrospectively by a multi-cancer early detection test.

|May 27, 2024
Strong association between reduction of late-stage cancers and reduction of cancer-specific mortality in meta-regression of randomized screening trials across multiple cancer types.

James Y Dai, E Georg Luebeck, Ellen T Chang

|Feb 02, 2024
Clinical performance and utility: A microsimulation model to inform the design of screening trials for a multi-cancer early detection test.

James Y Dai, Jing Zhang, Jerome V Braun

|Aug 09, 2023
Germline Genetic Variants Associated with Somatic TMPRSS2:ERG Fusion Status in Prostate Cancer: A Genome-Wide Association Study.

Chaoran Ma, Xiaoyu Wang, James Y Dai

|Mar 06, 2023
Timing and duration of bevacizumab treatment and survival in patients with recurrent ovarian, fallopian tube, and peritoneal cancer: a multi-institution study.

Talayeh S Ghezelayagh, Emily S Wu, Emma L Barber

|Jun 16, 2022
eQTL Set-Based Association Analysis Identifies Novel Susceptibility Loci for Barrett Esophagus and Esophageal Adenocarcinoma.

Xiaoyu Wang, Puya Gharahkhani, David M Levine

Pageof 2

Frequent Collaborators

3 joint publications

Xiaoyu Wang

3 joint publications

Earl Hubbell

2 joint publications

E Georg Luebeck

1 joint publications

Ching-Yun Wang